Lee's Pharmaceutical Holdings Limited (Lee's Pharm) is a leading biopharmaceutical company with over 25 years of experience in the pharmaceutical industry in China. Listed on the Stock Exchange of Hong Kong, the company is dedicated to providing innovative products that fight diseases and improve the overall health and quality of life of individuals in Asia. Since its establishment in 1994, Lee's Pharm has focused on the development, manufacture, and sales of proprietary biopharmaceutical products, mainly in the cardiovascular and infectious disease areas.

The company has achieved significant growth over the years and expanded its operations to include various therapeutic areas such as paediatrics, woman health, rare diseases, dermatology, oncology, and ophthalmology. Lee's Pharm is known for its strong partnerships with over 30 international companies and markets more than 25 proprietary, generic, and licensed-in pharmaceutical products across Mainland China, Hong Kong, Macau, and Taiwan. The company has a robust infrastructure in drug development, clinical trials, manufacturing, sales, and marketing, ensuring the availability of a full range of high-quality pharmaceutical products.

With a commitment to innovation, excellence, and resilience, Lee's Pharm continues to contribute to the advancement of healthcare and the well-being of individuals in Asia